Zobrazeno 1 - 10
of 170
pro vyhledávání: '"V. Ptushkin"'
Autor:
A. Petrenko, M. Kislova, E. Dmitrieva, T. Novikova, M. Kislitsyna, T. Obukhova, E. Nikitin, V. Ptushkin
Publikováno v:
HemaSphere, Vol 6, Pp 552-553 (2022)
Externí odkaz:
https://doaj.org/article/e1329253c8664dada47794424c9472bb
Autor:
E. Likold, B. Biderman, I. Fevraleva, N. Severina, E. Dmitrieva, E. Nikitin, V. Ptushkin, A. Sudarikov
Publikováno v:
HemaSphere, Vol 6, Pp 1754-1755 (2022)
Externí odkaz:
https://doaj.org/article/ed72af77a27847a7b4f33deb8ddf1040
Autor:
O. Yu. Vinogradova, M. M. Pankraskina, A. L. Neverova, D. I. Shikhbabaeva, M. A. Murzabekova, M. V. Chernikov, A. V. Popova, V. P. Kosenkova, L. B. Egoryan, V. V. Ptushkin
Publikováno v:
Онкогематология, Vol 19, Iss 3, Pp 16-33 (2024)
Background. Currently, targeted therapy is the most promising for the treatment of myelofibrosis (MF). Today, the results of many years of experience with the use of ruxolitinib, including outside randomized trials and the identification of predictor
Externí odkaz:
https://doaj.org/article/32b92dd0c58149d28216d7e1ea000c8a
Autor:
Olga Yu. Vinogradova, Mikhail V. Chernikov, Anna L. Neverova, Victoria P. Kosenkova, Yulia B. Kochkareva, Dzhariiat I. Shikhbabaeva, Maria M. Pankrashkina, Nikolai N. Sharkunov, Vadim V. Ptushkin
Publikováno v:
Современная онкология, Vol 26, Iss 2, Pp 149-158 (2024)
Background. The COVID-19 pandemic, which swept the world in 2020–2021, had a significant impact on the epidemiological picture of hematological malignancies. Aim. To study the dynamics of epidemiological indicators of five chronic hemoblastoses
Externí odkaz:
https://doaj.org/article/757c2e57a82b414a9a93d1a17c90ff5d
Autor:
D. I. Shikhbabaeva, O. Yu. Vinogradova, A. L. Neverova, M. M. Pankrashkina, M. V. Chernikov, E. O. Detkina, Yu. N. Kobzev, S. G. Malakho, V. V. Ptushkin
Publikováno v:
Онкогематология, Vol 18, Iss 4, Pp 78-89 (2023)
Background. Mastocytosis is a heterogeneous group of diseases that are characterized by excessive proliferation and accumulation of clonal (neoplastic) mast cells in one or more organs. Advanced variants of systemic mastocytosis (aggressive systemic
Externí odkaz:
https://doaj.org/article/b0824ac883044800950c5541dea6c7c5
Autor:
O. Yu. Vinogradova, D. I. Shikhbabaeva, Yu. N. Kobzev, A. L. Neverova, M. M. Pankraskina, S. G. Malakho, M. V. Chernikov, M. A. Murzabekova, A. G. Popova, L. B. Egoryan, A. V. Krechetova, V. V. Ptushkin
Publikováno v:
Онкогематология, Vol 18, Iss 4, Pp 115-134 (2023)
Background. Targeted therapy is the most promising in the treatment of myelofibrosis, but it is necessary to search for the reasons limiting its effectiveness. There are known factors negatively affecting the development of myelofibrosis, but data on
Externí odkaz:
https://doaj.org/article/acfa0f73165445de81595ace088e5592
Autor:
A. D. Kulagin, E. A. Lukina, V. V. Ptushkin, M. P. Kostinov, E. G. Arshanskaya, T. N. Babaeva, T. I. Ksenzova, Z. T. Fidarova, M. V. Marchenko
Publikováno v:
Онкогематология, Vol 18, Iss 3, Pp 140-144 (2023)
On June 24, 2023, an Expert Council was held in St. Petersburg, during which leading experts in the field of hematology discussed current achievements and answered a number of unresolved issues of targeted therapy of paroxysmal nocturnal hemoglobinur
Externí odkaz:
https://doaj.org/article/7a0ccf75cd9245f48e4ac2e80b45a701
Autor:
M. A. Granatkin, E. A. Nikitin, M. I. Kislova, E. S. Mikhailov, V. A. Doronin, S. V. Minenko, M. M. Okuneva, A. V. Antonova, N. V. Degtyareva, M. E. Pochtar, S. A. Lugovskaya, Yu. N. Kobzev, V. V. Ptushkin, E. V. Rimashevskaya
Publikováno v:
Онкогематология, Vol 18, Iss 1, Pp 12-19 (2023)
Background. Treatment results in patients with relapsed and refractory acute myeloid leukemia (AML) remain unsatis‑factory. Treatment options for these patients are limited.Aim. To retrospectively analyze the efficacy and safety of combined therapy
Externí odkaz:
https://doaj.org/article/ef278213eaf0426fb5eff65766f77a94
Autor:
E. V. Usikova, K. D. Kaplanov, V. I. Vorob'ev, T. I. Lobanova, M. A. Ul'yanova, D. G. Kisilichina, Yu. N. Kobzev, D. I. Shikhbabaeva, O. Yu. Vinogradova, V. V. Ptushkin
Publikováno v:
Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, Vol 12, Iss 6, Pp 64-77 (2023)
Relevance and goals. Treatment of patients with acute myeloid leukemia has traditionally been highly intensive and includes induction therapy using cytarabine and anathracyclines. In addition to new opportunities in the treatment of acute myeloid leu
Externí odkaz:
https://doaj.org/article/0b6810be75d24a37be9a671bc5da96a4
Autor:
O. Yu. Vinogradova, M. M. Pankrashkina, D. I. Shikhbabaeva, M. V. Chernikov, A. L. Neverova, V. L. Ivanova, E. A. Nikitin, E. V. Usikova, V. V. Ptushkin
Publikováno v:
Онкогематология, Vol 17, Iss 4, Pp 94-105 (2022)
Background. For many years the primary aim of treatment strategy for ph-negative myeloproliferative neoplasms has been to restrain disease progression, with lasting relief and management of symptoms to improve patients’ quality of life. Generally,
Externí odkaz:
https://doaj.org/article/12385d86efa6423ebfe6e5d6fce6e692